These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3172677)

  • 1. Lipoprotein pattern in long-term diabetes of an at least 35 years' duration. Results of the Erfurt Study.
    Schauer UJ; Panzram G; Pissarek D; Rühling K; Winkler L; Lundershausen R
    Klin Wochenschr; 1988 Aug; 66(15):694-8. PubMed ID: 3172677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of coronary heart disease with serum lipid and apolipoprotein concentrations in long-term diabetes. Results of the Erfurt study.
    Schauer UJ; Pissarek D; Panzram G
    Acta Diabetol Lat; 1989; 26(1):35-42. PubMed ID: 2501960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipids and apolipoproteins in relation to glycaemic control and diabetic nephropathy in long-term survivors of diabetes: results of the Erfurt Study.
    Schauer UJ; Pissarek D; Lundershausen R; Rühling K; Winkler L; Panzram G
    Exp Clin Endocrinol; 1988 Mar; 92(3):280-6. PubMed ID: 3267003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease.
    Laakso M; Pyörälä K
    Atherosclerosis; 1988 Nov; 74(1-2):55-63. PubMed ID: 3214481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels.
    Uusitupa M; Siitonen O; Voutilainen E; Aro A; Hersio K; Pyörälä K; Penttilä I; Ehnholm C
    Diabetes Care; 1986; 9(1):17-22. PubMed ID: 3081307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations.
    Walden CE; Knopp RH; Wahl PW; Beach KW; Strandness E
    N Engl J Med; 1984 Oct; 311(15):953-9. PubMed ID: 6472421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Brunner D
    Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein abnormalities in insulin-dependent diabetes mellitus.
    Winocour PH; Durrington PN; Ishola M; Anderson DC
    Lancet; 1986 May; 1(8491):1176-8. PubMed ID: 2871420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
    Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G
    Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
    Gonzélez C; Stern MP; Mitchell BD; Valdez RA; Haffner SM; Pérez BA
    Diabetes Care; 1994 May; 17(5):397-404. PubMed ID: 8062606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
    Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Lefrandt JD
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations.
    Falko JM; Parr JH; Simpson RN; Wynn V
    Am J Med; 1987 Oct; 83(4):641-7. PubMed ID: 3674053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased LDL cholesterol in non-insulin-dependent diabetics with maculopathy.
    Mohan R; Mohan V; Susheela L; Ramachandran A; Viswanathan M
    Acta Diabetol Lat; 1984; 21(1):85-9. PubMed ID: 6730849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.
    Hernández C; Chacón P; García-Pascual L; Simó R
    Diabetes Care; 2001 Feb; 24(2):350-5. PubMed ID: 11213891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus.
    Rubiés-Prat J; Reverter JL; Sentí M; Pedro-Botet J; Salinas I; Lucas A; Nogués X; Sanmartí A
    Diabetes Care; 1993 Aug; 16(8):1081-6. PubMed ID: 8375237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.
    Diabetes Atorvastin Lipid Intervention (DALI) Study Group
    Diabetes Care; 2001 Aug; 24(8):1335-41. PubMed ID: 11473066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.